Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01685073 · ClinicalTrials.gov registry record · Phase 2
The Role of Sleep in the Treatment of Cannabis Use Disorders
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 127
- Enrollment target
NCT01685073: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT01685073 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 127 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01685073, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 127 participants
- Enrollment target
Study Summary
The number of people seeking treatment for marijuana-related problems is on the rise, yet there is no currently accepted medication proven to help them quit. Frequent marijuana users have reported that they have trouble sleeping when they try to quit, and that the loss of sleep can lead to relapse. This research is designed to measure the severity of sleep problems in people as they are trying to quit heavy use of marijuana, and to investigate whether extended-release zolpidem (Ambien CR®) can improve quit rates among people trying to stop using marijuana.
Interventions
- BEHAVIORAL MET/CBT
- DRUG Zolpidem extended-release
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2012-09 |
| Est. Completion | 2018-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01685073
The ClinicalTrials.gov registry entry for NCT01685073 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MET/CBT is the first listed.
NCT01685073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01685073 about?
NCT01685073 is a clinical study titled "The Role of Sleep in the Treatment of Cannabis Use Disorders". The number of people seeking treatment for marijuana-related problems is on the rise, yet there is no currently accepted medication proven to help them quit. Frequent marijuana users have reported that they have trouble sleeping when they try to quit, and that the loss of sleep can lead to relapse. ...
What is the current status of trial NCT01685073?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 127 participants. The study started on 2012-09. Estimated completion is 2018-07.
What interventions are being tested in trial NCT01685073?
The interventions under investigation include: MET/CBT (BEHAVIORAL), Zolpidem extended-release (DRUG).
Who is sponsoring clinical trial NCT01685073?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.